500 related articles for article (PubMed ID: 25430900)
1. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.
Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T
Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900
[TBL] [Abstract][Full Text] [Related]
2. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
[TBL] [Abstract][Full Text] [Related]
3. Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.
Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
J Ocul Pharmacol Ther; 2013 Apr; 29(3):290-7. PubMed ID: 23425430
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.
Alezzandrini A; Hubatsch D; Alfaro R
Adv Ther; 2014 Sep; 31(9):975-85. PubMed ID: 25138224
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension.
Wang N; Lu DW; Pan Y; Astakhov Y; Iureva T; Adewale A; Walker TM
Clin Ophthalmol; 2020; 14():221-230. PubMed ID: 32158181
[TBL] [Abstract][Full Text] [Related]
6. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
7. Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
Topouzis F; Goldberg I; Bell K; Tatham AJ; Ridolfi A; Hubatsch D; Nicolela M; Denis P; Lerner SF
Eur J Ophthalmol; 2021 Jan; 31(1):103-111. PubMed ID: 31595773
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
9. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
Jin SW; Lee SM
J Ocul Pharmacol Ther; 2018 Apr; 34(3):274-279. PubMed ID: 29297751
[TBL] [Abstract][Full Text] [Related]
11. Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies.
Realini T; Nguyen QH; Katz G; DuBiner H
Eye (Lond); 2013 Jul; 27(7):841-7. PubMed ID: 23640612
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.
Feldman RM; Katz G; McMenemy M; Hubatsch DA; Realini T
Am J Ophthalmol; 2016 May; 165():188-97. PubMed ID: 26940161
[TBL] [Abstract][Full Text] [Related]
13. 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.
Weinreb RN; Bacharach J; Fechtner RD; Kahook MY; Wirta D; Burmaster S; Meng X; Hubatsch DA
Ophthalmology; 2019 Aug; 126(8):1095-1104. PubMed ID: 30403988
[TBL] [Abstract][Full Text] [Related]
14. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
García-López A; Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G
J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
[TBL] [Abstract][Full Text] [Related]
17. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
Kóthy P; Holló G
Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
[TBL] [Abstract][Full Text] [Related]
18. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
Day DG; Hollander DA
Curr Med Res Opin; 2008 May; 24(5):1435-42. PubMed ID: 18402717
[TBL] [Abstract][Full Text] [Related]
19. The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
Seibold LK; DeWitt PE; Kroehl ME; Kahook MY
J Ocul Pharmacol Ther; 2017 Apr; 33(3):161-169. PubMed ID: 28129020
[TBL] [Abstract][Full Text] [Related]
20. Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.
Greig SL; Deeks ED
Drugs Aging; 2015 Mar; 32(3):251-60. PubMed ID: 25732405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]